Yi L, Wang Y, Wang J, Chen Y, Huang W, Liao Y
RSC Med Chem. 2024; .
PMID: 39723232
PMC: 11667242.
DOI: 10.1039/d4md00846d.
Kron N, Fieber L, Baker L, Campbell C, Schmale M
Dev Comp Immunol. 2024; 159:105211.
PMID: 38885747
PMC: 11378725.
DOI: 10.1016/j.dci.2024.105211.
Shahbaz M, Kuivanen S, Lampinen R, Mussalo L, Hron T, Zavodna T
J Neuroinflammation. 2023; 20(1):299.
PMID: 38098019
PMC: 10722731.
DOI: 10.1186/s12974-023-02979-4.
Suo X, Wang J, Wang D, Fan G, Zhu M, Fan B
J Virol. 2023; 97(11):e0120923.
PMID: 37843366
PMC: 10688372.
DOI: 10.1128/jvi.01209-23.
Consonni F, Durante B, Manfredi M, Bleve A, Pandolfo C, Garlatti V
Front Immunol. 2023; 14:1168455.
PMID: 37063865
PMC: 10090695.
DOI: 10.3389/fimmu.2023.1168455.
An Overview of Fluvoxamine and its Use in SARS-CoV-2 Treatment.
Arishi N, Althomali N, Dighriri I, Alharthi M, Alqurashi G, Musharraf R
Cureus. 2023; 15(1):e34158.
PMID: 36843775
PMC: 9949685.
DOI: 10.7759/cureus.34158.
Optimization of 5'UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells.
Chen S, Xu C, Chang C, Chao T, Lin C, Fu P
Appl Microbiol Biotechnol. 2023; 107(7-8):2451-2468.
PMID: 36843199
PMC: 9968647.
DOI: 10.1007/s00253-023-12442-2.
Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications.
Kabekkodu S, Chakrabarty S, Jayaram P, Mallya S, Thangaraj K, Singh K
Mitochondrion. 2023; 69:43-56.
PMID: 36690315
PMC: 9854144.
DOI: 10.1016/j.mito.2023.01.005.
Duck Plague Virus Negatively Regulates IFN Signaling to Promote Virus Proliferation JNK Signaling Pathway.
Wu L, Tian B, Wang M, Cheng A, Jia R, Zhu D
Front Immunol. 2022; 13:935454.
PMID: 35837399
PMC: 9275408.
DOI: 10.3389/fimmu.2022.935454.
Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.
Mahdi M, Herman L, Rethelyi J, Balint B
Int J Mol Sci. 2022; 23(7).
PMID: 35409171
PMC: 8998734.
DOI: 10.3390/ijms23073812.
Prevention, treatment and potential mechanism of herbal medicine for Corona viruses: A review.
Liu Y, Zhou Y, Jiang C, Liu J, Chen D
Bioengineered. 2022; 13(3):5480-5508.
PMID: 35184680
PMC: 8973820.
DOI: 10.1080/21655979.2022.2036521.
A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine.
Paparo L, Maglio M, Cortese M, Bruno C, Capasso M, Punzo E
Molecules. 2022; 27(3).
PMID: 35164139
PMC: 8838168.
DOI: 10.3390/molecules27030862.
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment.
Drozdzal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybycinski J
Drug Resist Updat. 2022; 59:100794.
PMID: 34991982
PMC: 8654464.
DOI: 10.1016/j.drup.2021.100794.
The role of lipids in the pathophysiology of coronavirus infections.
Zandi M, Hosseini P, Soltani S, Rasooli A, Moghadami M, Nasimzadeh S
Osong Public Health Res Perspect. 2021; 12(5):278-285.
PMID: 34719219
PMC: 8561023.
DOI: 10.24171/j.phrp.2021.0153.
Heat shock protein 70 could enhance porcine epidemic diarrhoea virus replication by interacting with membrane proteins.
Park J, Ryu J, Park J, Hong E, Shin H
Vet Res. 2021; 52(1):138.
PMID: 34717778
PMC: 8557036.
DOI: 10.1186/s13567-021-01006-9.
The PERK/PKR-eIF2α Pathway Negatively Regulates Porcine Hemagglutinating Encephalomyelitis Virus Replication by Attenuating Global Protein Translation and Facilitating Stress Granule Formation.
Shi J, Li Z, Xu R, Zhang J, Zhou Q, Gao R
J Virol. 2021; 96(1):e0169521.
PMID: 34643429
PMC: 8754228.
DOI: 10.1128/JVI.01695-21.
DJ-1-Nrf2 axis is activated upon murine β-coronavirus infection in the CNS.
Kundu S, Saadi F, Sengupta S, Antony G, Raveendran V, Kumar R
Brain Disord. 2021; 4:100021.
PMID: 34514445
PMC: 8418700.
DOI: 10.1016/j.dscb.2021.100021.
Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.
Ayatollahi S, Sharifi-Rad J, Tsouh Fokou P, Mahady G, Suleria H, Kapuganti S
Front Pharmacol. 2021; 12:575877.
PMID: 34267652
PMC: 8277242.
DOI: 10.3389/fphar.2021.575877.
Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.
Siri M, Dastghaib S, Zamani M, Rahmani-Kukia N, Roustai Geraylow K, Fakher S
Int J Mol Sci. 2021; 22(11).
PMID: 34206057
PMC: 8199451.
DOI: 10.3390/ijms22115992.
Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism.
Policard M, Jain S, Rego S, Dakshanamurthy S
Virus Res. 2021; 301:198464.
PMID: 34058265
PMC: 8163696.
DOI: 10.1016/j.virusres.2021.198464.